Clinical Trial Update: A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TG103 Injection evaluating management of non-diabetic overweight or obesity; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• TG103 Injection

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED